Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01006174 · ClinicalTrials.gov registry record · NA
Dietary Lipids as Primary Modulators of Carotenoid Absorption in Vegetables
A NA study of Absorption of Carotenoids From Vegetables, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT01006174: Completed NA study of Absorption of Carotenoids From Vegetables, sponsored by Purdue University.
NCT01006174 is a NA study of Absorption of Carotenoids From Vegetables that has completed, run by Purdue University. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01006174, a NA study of Absorption of Carotenoids From Vegetables, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine how dietary fats and oils influence the absorption of beneficial plant pigments (carotenoids) from vegetables. The study will examine changes in blood carotenoids in response to eating a salad with different fats/oils.
Conditions Studied
Interventions
- OTHER Soybean Oil
- OTHER Canola Oil
- OTHER Butter
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-05 |
| Phase | NA |
What the finished NCT01006174 record still lists
NCT01006174 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Absorption of Carotenoids From Vegetables appearing as the primary indexed condition, and to 3 interventions - of which Soybean Oil is the first listed.
NCT01006174 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT01006174 about?
NCT01006174 is a clinical study titled "Dietary Lipids as Primary Modulators of Carotenoid Absorption in Vegetables". The purpose of this research study is to determine how dietary fats and oils influence the absorption of beneficial plant pigments (carotenoids) from vegetables. The study will examine changes in blood carotenoids in response to eating a salad with different fats/oils.
What is the current status of trial NCT01006174?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2009-03. Estimated completion is 2010-05.
What conditions does trial NCT01006174 study?
This clinical trial studies the following conditions: Absorption of Carotenoids From Vegetables.
What interventions are being tested in trial NCT01006174?
The interventions under investigation include: Soybean Oil (OTHER), Canola Oil (OTHER), Butter (OTHER).
Who is sponsoring clinical trial NCT01006174?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01006174 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01006174's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia